Most Viewed Abstracts
1. Report Shows Shift in Starting Salaries for Physicians 2. 2008 Exclusive Survey—Earnings: Good news for primary care income 3. Medicare pay-for-reporting effort draws fire from frustrated doctors 4. Debunking Myths in the US Healthcare System 5. Doctors and the DEA Free full text
Top Ten Searches
rosacea eczema alopecia ceramide keratosis pityriasis basal cell melanoma keratosis purpuraYour Article Summary
Treatments for psoriasis and the risk of malignancy
Journal of the American Academy of Dermatology, 06/05/09
Patel RV et al. - Many of the therapies for moderate to severe psoriasis, including PUVA, traditional systemic therapies, and some biologic therapies, may increase the risk of malignancy. Appropriate patient counseling and selection, as well as clinical follow-up, are necessary to maximize safety with these agents.
Today in Dermatologic Oncology...keeping you current
Receive free subspecialty "5-minute updates" via email
A practical approach to using methotrexate
Dermatology in Practice, 10/09/09
Positron emission tomography in early detection of relapse in high-risk melanoma patients: a retrospective review
Community Oncology , 10/09/09
Surgical excision margins for primary cutaneous melanoma
Cochrane Reviews, 10/09/09
Today in Psoriasis...keeping you current
Receive free subspecialty "5-minute updates" via email
A practical approach to using methotrexate
Dermatology in Practice, 10/09/09
Pediatric psoriasis: an update
Therapeutics and Clinical Risk Management, 10/22/09
Ustekinumab for the treatment of plaque psoriasis
Expert Review of Dermatology, 10/13/09
Sponsor
Article Search
Sponsor


See Latest Articles


